Department of Physiological Chemistry II, Theodor-Boveri Institute for Life Sciences (Biocenter), University of Wuerzburg, 97074 Wuerzburg, Germany.
FEBS J. 2010 Jan;277(1):106-18. doi: 10.1111/j.1742-4658.2009.07480.x. Epub 2009 Nov 27.
Cytokine receptors are crucial for the maintenance, regulation and growth of cells in multicellular organisms. As a common theme in cytokine signalling, single-span receptor chains are assembled in the cell membrane by a ligand enabling cross-activation of the aligned cytoplasmic receptor domains. Nature has created many variations of how this general principle is realized in a cell. Here we focus on cytokines of the four-helix bundle (interleukins) and cystine knot (transforming growth factor-beta/bone morphogenetic proteins) families. Upon activation, receptor chains can form duos, trios, quartets and even larger assemblies. The structure of the extracellular ligand-binding domain of a number of these receptor complexes has now been elucidated, providing the molecular basis for understanding the functional relevance of mechanistic diversity in a cellular context. Biochemical and structural data have revealed ligand recognition mechanisms. Contact sites are usually large and rather flat. A limited number of contact residues provide most of the binding free energy (hot spots). Leaks in hydrophobic seals appear to provide a mechanism for adjusting the affinity of a hot spot interaction (scalability). Bone morphogenetic protein ligands are often promiscuous and interact not only with receptors, but also with a multitude of modulator proteins, which inhibit or enhance bone morphogenetic protein signalling. Cytokine receptor systems offer promising targets for drug development. Information on the structure and the activation mechanism provides leads for developing biologicals, such as engineered cytokines, cytokine mutants acting as receptor antagonists and receptor extracellular ligand-binding domain-Fc fusion proteins. Possible indications exist in the areas of haematology, immunology, inflammation, cancer and tissue regeneration.
细胞因子受体对于多细胞生物中细胞的维持、调节和生长至关重要。作为细胞因子信号转导的一个共同主题,配体能够在细胞膜中组装单跨受体链,从而使对齐的细胞质受体结构域发生交叉激活。自然界创造了许多变体,以实现这一普遍原则在细胞中的实现。在这里,我们重点关注四螺旋束(白细胞介素)和半胱氨酸结(转化生长因子-β/骨形态发生蛋白)家族的细胞因子。受体链在被激活后可以形成二聚体、三聚体、四聚体甚至更大的复合物。现在已经阐明了这些受体复合物中许多的细胞外配体结合域的结构,为理解细胞环境中机制多样性的功能相关性提供了分子基础。生化和结构数据揭示了配体识别机制。接触位点通常较大且相当平坦。数量有限的接触残基提供了大部分结合自由能(热点)。疏水性密封件的泄漏似乎为调整热点相互作用的亲和力(可扩展性)提供了一种机制。骨形态发生蛋白配体通常是混杂的,不仅与受体相互作用,还与多种调节剂蛋白相互作用,这些调节剂蛋白抑制或增强骨形态发生蛋白信号转导。细胞因子受体系统为药物开发提供了有前景的靶点。关于结构和激活机制的信息为开发生物制剂提供了线索,例如工程细胞因子、作为受体拮抗剂的细胞因子突变体以及受体细胞外配体结合域-Fc 融合蛋白。在血液学、免疫学、炎症、癌症和组织再生等领域存在可能的适应症。